EcoDrugPlus

Exportin 1

Ensembl ID : ENSMZEG00005005105
Gene Symbol: XPO1
3 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSMZEG00005018158
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSMZEG00005015843
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSMZEG00005016673
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSMZEG00005005867
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Female Protein-Like

Ensembl ID : ENSMZEG00005015150
Gene Symbol: LOC101466570
2 Cross references
386 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSMZEG00005023143
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A

Ensembl ID : ENSMZEG00005007656
Gene Symbol: LOC101469987
4 Cross references
205 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSMZEG00005010727
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSMZEG00005002787
Gene Symbol: FGFR3
3 Cross references
193 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSMZEG00005021867
Gene Symbol: FLT1
3 Cross references
198 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSMZEG00005010055
Gene Symbol: FLT4
3 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).